Form 4: Ironwood Pharmaceuticals Director Acquires Shares as Part of Compensation Policy

Director Duane Jon R. acquired 24,311 shares of Ironwood Pharmaceuticals Class A Common Stock on June 18, 2024, as part of the company's non-employee director compensation policy.

Summary

• On June 18, 2024, Duane Jon R., a director of Ironwood Pharmaceuticals, acquired 24,311 shares of Class A Common Stock.
• The acquisition was part of the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
• The restricted stock vests fully on the date immediately preceding the next annual meeting of stockholders.
• Following the transaction, Duane Jon R. directly owns 145,339 shares of Ironwood Pharmaceuticals Class A Common Stock.

Sentiment

Score: 7

Explanation: Routine director share acquisition under existing compensation policy; indicates confidence but not a major event.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The non-employee director compensation policy aligns director interests with shareholder value.

Industry Context

Director share acquisitions are common and often tied to compensation packages designed to align management and shareholder interests.

Stakeholder Impact

• The share acquisition aligns the director's interests with those of the shareholders.

Key Dates